Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-27
2005-09-27
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S311100, C548S316400, C548S331500, C548S326500, C548S340100, C548S341100, C548S364100, C548S371400, C548S371700, C548S372100, C548S375100, C548S376100, C514S398000, C514S399000, C514S406000, C514S407000
Reexamination Certificate
active
06949578
ABSTRACT:
The present invention relates to a class of compounds represented by the Formula Ior a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3and/or αvβ5integrin.
REFERENCES:
patent: 5710171 (1998-01-01), Dinsmore et al.
Chen Barbara
Clare Michael
Gasiecki Alan F.
Khanna Ish Kumar
Lu Hwang-Fun
Habte Kahsay
Harness Dickey & Pierce PLC
Pharmacia Corporation
Raymond Richard L.
LandOfFree
Cycloalkyl alkanoic acids as integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkyl alkanoic acids as integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl alkanoic acids as integrin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435494